郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

病毒感染Ultrapotent class I neutralizing antibodies post Omicron breakthrough infection overcome broad SARS-CoV-2 escape variants.

期刊：EBioMedicine发表年份：2024作者：Mengxiao Luo; Runhong Zhou; Bingjie Tang; Hang Liu; Bohao Chen; Na Liu; Yufei Mo; Pengfei Zhang; Ye Lim Lee; Jonathan Daniel Ip; Allen Wing-Ho Chu; Wan-Mui Chan; Hiu-On Man; Yuting Chen; Kelvin Kai-Wang To; Kwok-Yung Yuen; Shangyu Dang; Zhiwei Chen
阅读更多 →

病毒感染Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies.

期刊：Cell host & microbe发表年份：2021作者：Dongyan Zhou; Jasper Fuk-Woo Chan; Biao Zhou; Runhong Zhou; Shuang Li; Sisi Shan; Li Liu; Anna Jinxia Zhang; Serena J Chen; Chris Chung-Sing Chan; Haoran Xu; Vincent Kwok-Man Poon; Shuofeng Yuan; Cun Li; Kenn Ka-Heng Chik; Chris Chun-Yiu Chan; Jianli
阅读更多 →

病毒感染A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.

期刊：Journal of virology发表年份：2022作者：Rana Abdelnabi; Caroline S Foo; Suzanne J F Kaptein; Robbert Boudewijns; Laura Vangeel; Steven De Jonghe; Dirk Jochmans; Birgit Weynand; Johan Neyts
阅读更多 →

病毒感染Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.

期刊：The Journal of infectious diseases发表年份：2024作者：Timothy D Carroll; Talia Wong; Mary Kate Morris; Clara Di Germanio; Zhong-Min Ma; Mars Stone; Erin Ball; Linda Fritts; Arjun Rustagi; Graham Simmons; Michael Busch; Christopher J Miller
阅读更多 →